HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael P Manos Selected Research
Michael P Manos Research Topics
Disease
12
Neoplasms (Cancer)
11/2023 - 01/2017
9
Melanoma (Melanoma, Malignant)
04/2024 - 01/2017
2
Neoplasm Metastasis (Metastasis)
01/2022 - 10/2021
1
Triple Negative Breast Neoplasms
01/2022
1
Disease Progression
11/2021
1
Brain Neoplasms (Brain Tumor)
10/2021
1
COVID-19
05/2021
1
Adenocarcinoma of Lung
01/2021
1
Basal Cell Carcinoma (Rodent Ulcer)
01/2020
Drug/Important Bio-Agent (IBA)
6
Immune Checkpoint Inhibitors
IBA
11/2023 - 08/2017
3
Ipilimumab
IBA
10/2021 - 01/2017
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2023 - 01/2017
2
Proteins (Proteins, Gene)
FDA Link
11/2023 - 08/2019
2
B7-H1 Antigen
IBA
01/2022 - 01/2017
2
pembrolizumab
IBA
01/2022 - 08/2017
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2017
1
Chromatin
IBA
04/2024
1
Angiogenesis Inhibitors
IBA
11/2023
1
Circulating Tumor DNA
IBA
01/2022
1
atezolizumab
IBA
01/2022
1
Glucocorticoids
IBA
11/2021
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
10/2021
1
Nivolumab
IBA
10/2021
1
Troponin
IBA
05/2021
1
Antigens
IBA
01/2021
1
birinapant
IBA
01/2021
1
Double-Stranded RNA (RNA, Double Stranded)
IBA
01/2020
1
X-Linked Inhibitor of Apoptosis Protein
IBA
08/2019
1
Survivin
IBA
08/2019
1
Peptide Library
IBA
08/2019
1
Epitopes
IBA
08/2019
1
Programmed Cell Death 1 Receptor
IBA
01/2017
1
Bevacizumab (Avastin)
FDA Link
01/2017
1
Cytokines
IBA
01/2017
Therapy/Procedure
10
Therapeutics
01/2022 - 01/2017
3
Immunotherapy
04/2024 - 01/2020
1
Drug Therapy (Chemotherapy)
01/2022
1
Aftercare (After-Treatment)
01/2020